GlassScriptPhysician profile
Oneal W Koger
NPI 1962599530
$4,128.15
in general payments reported to CMS, 2019-2025
20 companies · $771 in 2025
The $771 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,210 · 2020: $236 · 2021: $332 · 2022: $439 · 2023: $533 · 2024: $607 · 2025: $771.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,847 · Education: $64.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,846.51 |
| Education | $64.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $949.88 | 2019-2025 | Tremfya, Simponi Aria, Stelara |
| Abbvie INC. | $726.64 | 2019-2025 | |
| Biofrontera INC. | $471.91 | 2019 | |
| Pfizer INC. | $438.47 | 2019-2024 | |
| Sun Pharmaceutical Industries INC. | $396.73 | 2019-2025 | Absorica Ld, Winlevi |
| Novartis Pharmaceuticals Corporation | $356.69 | 2019-2025 | |
| Lilly USA, LLC | $178.87 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $110.65 | 2019-2020 | |
| Organon LLC | $99.32 | 2025 | |
| Dermavant Sciences, INC. | $62.00 | 2023-2024 | Vtama |
| Amgen INC. | $55.26 | 2024 | Otezla |
| Ucb, INC. | $52.97 | 2023-2024 | Bimzelx |
| Mission Pharmacal Company | $42.23 | 2019 | |
| Leo Pharma INC. | $41.66 | 2023-2025 | Adbry, Anzupgo |
| Genzyme Corporation | $39.74 | 2019-2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $27.18 | 2019-2025 | Jublia |
| Arcutis Biotherapeutics, INC. | $23.71 | 2023 | |
| Epi Health, LLC | $22.03 | 2022 | |
| Dermira, INC. | $17.75 | 2020 | |
| Genentech USA, INC. | $14.46 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Oneal Koger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.